ChartRow logo
ChartRow
Stocks and ETFs
Sign in
BMY
Bristol-Myers Squibb CompanyStock · Healthcare
$58.13+$1.69 (+2.99%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

How Bristol-Myers Squibb makes money

Fiscal year

How does Bristol-Myers Squibb make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year. Straight from SEC filings.

Bristol-Myers Squibb Company · FY2025 · year ended 2025-12-31
Revenue$48.2BGross profit$34.3B · 71%Cost of revenue$13.9B · 29%Operating income$17.0B · 35%Operating expenses$17.2B · 36%R&D$10.0B · 21%SG&A$7.3B · 15%Pre-tax income$9.3B · 19%Other expense$7.7B · 16%Net income$7.1B · 15%Income tax$2.3B · 5%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.